Nuritas
PrivateLast Round
Series C
Dec 20, 2024
Total Funding Raised
$146.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuritas is a biotechnology company that utilizes a platform combining artificial intelligence and genomics to discover and unlock natural bioactive peptides for use in dietary supplements, functional foods, and cosmetics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuritas Comparables
Compare Nuritas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shiru | 87% | |
| Brightseed | 83% | |
| Protera | 81% | |
Nuritas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 20, 2024 | ||||
| Series B | Nov 11, 2021 | ||||
| Debt | Nov 29, 2018 | ||||
| Series A | Dec 20, 2017 | ||||
| Seed | Dec 7, 2016 | ||||
Seed | Oct 26, 2015 |
Key People
Founding team and executive leadership
Nuritas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cultivian Sandbox Ventures | Series B, Series A |
| Grosvenor Food & AgTech | Series C, Series B |
| McWin Capital Partners | Series C |
| European Investment Bank Group | Debt |
| M&G Investments | Series C |
| Cleveland Avenue | Series B |
| Clay Capital | Series A, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Exhibiting at Vitafoods Europe 2026 in Barcelona.
- Apr 24, 2026
Vivatis Pharma will now cover Poland, Czech Republic, Slovakia, and Baltic markets.
Nuritas Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuritas's valuation, stock price, and market status.